RRAS2 and neuroblastoma: However, to our knowledge, recurrent focal amplifications of MYC, ZFHX3, KRAS, RRAS2, and CYTH1 have not been reported in neuroblastoma primary tumors before (Supplementary Note 1 and Supplementary Fig. 3).